GRASP cerebrospinal fluid levels of phosphorylated tau protein (p-tau181p) (alzheimers disease subjects), eye color, intracranial aneurysm, obesity with early age of onset (age >2), paternal transmission distortion, schizophrenia, systolic blood pressure (sbp)